Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.70
Delayed Data
As of 3:59pm ET
 -0.46 / -5.02%
Today’s Change
6.97
Today|||52-Week Range
16.30
+21.51%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close9.16
Today’s open9.21
Day’s range8.48 - 9.24
Volume619,250
Average volume (3 months)583,582
Market cap$349.8M
Dividend yield--
Data as of 3:59pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc+0.05+0.39%
CCXIChemoCentryx Inc+0.02+0.29%
CNCEConcert Pharmaceutic...-0.08-0.56%
CRBPCorbus Pharmaceutica...0.000.00%
Data as of 3:59pm ET, 05/25/2017

Financials

Next reporting dateJune 12, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts